The Food And Drug Administration Gets New Tools To Spur Regulatory Science

Friday, May. 17th 2013 8:13 AM

A new law that renews and extends user-fee arrangements for drug and device approvals also aims to speed effective new therapies to patients and the market.

Posted on Friday, May. 17th 2013 8:13 AM | by Share of Cost | in Share of Cost | No Comments »

Leave a Reply

You must be logged in to post a comment.